Ghost Tree Capital, LLC
- SEC CIK
- 0001595851
- 最新申報
- 2024/11/14
2024 年第 3 季持倉
持倉截至 2024/9/30，2024/11/14 申報。只含多頭部位，變化是跟 2024 年第 2 季比股數。
- 持股檔數
- 51
- 較 2024 年第 2 季 −8
- 總值
- $2.93 億
- 較 2024 年第 2 季 +$586.4 萬 (+2.0%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| Biohaven LtdG1110E907 | CALL | 348,778 | $1,743 萬 | 5.9% | +348,778 | 新進 | – |
| SRPTSarepta Therapeutics, Inc. | COM | 120,000 | $1,499 萬 | 5.1% | +65,000+118.2% | 加碼 | 歷史 |
| NVONovo Nordisk A S | ADR | 110,000 | $1,310 萬 | 4.5% | +110,000 | 新進 | 歷史 |
| BPMCBlueprint Medicines Corp | COM | 140,000 | $1,295 萬 | 4.4% | +100,000+250.0% | 加碼 | 歷史 |
| AXSMAxsome Therapeutics, Inc. | COM | 135,000 | $1,213 萬 | 4.1% | −15,000−10.0% | 減碼 | 歷史 |
| TARSTarsus Pharmaceuticals, Inc. | COM | 350,000 | $1,151 萬 | 3.9% | +115,000+48.9% | 加碼 | 歷史 |
| CATXPerspective Therapeutics, Inc. | COM NEW | 750,000 | $1,001 萬 | 3.4% | −175,000−18.9% | 減碼 | 歷史 |
| CGONCG Oncology, Inc. | COM | 250,000 | $943.3 萬 | 3.2% | −10,000−3.8% | 減碼 | 歷史 |
| ROIVRoivant Sciences Ltd. | SHS | 800,000 | $923.2 萬 | 3.1% | −200,000−20.0% | 減碼 | 歷史 |
| PCVXVaxcyte, Inc. | COM | 80,000 | $914.2 萬 | 3.1% | −70,000−46.7% | 減碼 | 歷史 |
| VKTXViking Therapeutics, Inc. | COM | 140,000 | $886.3 萬 | 3.0% | +45,000+47.4% | 加碼 | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 450,000 | $866.3 萬 | 3.0% | +100,000+28.6% | 加碼 | 歷史 |
| JANXJanux Therapeutics, Inc. | COM | 190,000 | $863.2 萬 | 2.9% | +140,000+280.0% | 加碼 | 歷史 |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 52,500 | $783.9 萬 | 2.7% | −34,221−39.5% | 減碼 | 歷史 |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 150,000 | $766.5 萬 | 2.6% | −90,000−37.5% | 減碼 | 歷史 |
| SLNOSoleno Therapeutics Inc | COM | 150,000 | $757.4 萬 | 2.6% | −150,000−50.0% | 減碼 | 歷史 |
| TGTXTG Therapeutics, Inc. | COM | 310,000 | $725.1 萬 | 2.5% | −190,000−38.0% | 減碼 | 歷史 |
| RZLTRezolute, Inc. | COM NEW | 1,474,995 | $715.4 萬 | 2.4% | +53,494+3.8% | 加碼 | 歷史 |
| PHATPhathom Pharmaceuticals, Inc. | COM | 375,000 | $678.0 萬 | 2.3% | −225,000−37.5% | 減碼 | 歷史 |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 128,411 | $647.4 萬 | 2.2% | −171,589−57.2% | 減碼 | 歷史 |
| OLMAOlema Pharmaceuticals, Inc. | COM | 535,000 | $638.8 萬 | 2.2% | −15,000−2.7% | 減碼 | 歷史 |
| IMVTImmunovant, Inc. | COM | 215,000 | $613.0 萬 | 2.1% | −45,000−17.3% | 減碼 | 歷史 |
| INSMINSMED Inc | COM PAR $.01 | 75,000 | $547.5 萬 | 1.9% | +10,000+15.4% | 加碼 | 歷史 |
| EWTXEdgewise Therapeutics, Inc. | COM | 195,000 | $520.5 萬 | 1.8% | +195,000 | 新進 | 歷史 |
| REPLReplimune Group, Inc. | COM | 450,000 | $493.2 萬 | 1.7% | 00.0% | 不變 | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 175,000 | $445.6 萬 | 1.5% | +35,000+25.0% | 加碼 | 歷史 |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 2,150,000 | $432.1 萬 | 1.5% | +900,000+72.0% | 加碼 | 歷史 |
| RYTMRhythm Pharmaceuticals, Inc. | COM | 78,842 | $413.1 萬 | 1.4% | −38,546−32.8% | 減碼 | 歷史 |
| ANNXAnnexon, Inc. | COM | 650,000 | $384.8 萬 | 1.3% | +340,000+109.7% | 加碼 | 歷史 |
| KRROKorro Bio, Inc. | COM | 110,000 | $367.6 萬 | 1.3% | +10,000+10.0% | 加碼 | 歷史 |
| DYNDyne Therapeutics, Inc. | COM | 100,000 | $359.2 萬 | 1.2% | +100,000 | 新進 | 歷史 |
| ARVNArvinas, Inc. | COM | 145,000 | $357.1 萬 | 1.2% | +70,000+93.3% | 加碼 | 歷史 |
| CRBPCorbus Pharmaceuticals Holdings, Inc. | COM NEW | 160,000 | $330.1 萬 | 1.1% | −15,000−8.6% | 減碼 | 歷史 |
| BBOTBridgeBio Oncology Therapeutics, Inc. | CL A ORD SHS | 300,000 | $313.5 萬 | 1.1% | 00.0% | 不變 | 歷史 |
| NUVBNuvation Bio Inc. | COM CL A | 1,350,000 | $309.1 萬 | 1.1% | +200,000+17.4% | 加碼 | 歷史 |
| SVRASavara Inc | COM | 725,000 | $307.4 萬 | 1.0% | −325,876−31.0% | 減碼 | 歷史 |
| TNYATenaya Therapeutics, Inc. | COM | 1,500,000 | $289.5 萬 | 1.0% | +150,000+11.1% | 加碼 | 歷史 |
| RGNXREGENXBIO Inc. | COM | 265,000 | $278.0 萬 | 0.9% | +95,000+55.9% | 加碼 | 歷史 |
| CRVSCorvus Pharmaceuticals, Inc. | COM | 500,000 | $264.0 萬 | 0.9% | +500,000 | 新進 | 歷史 |
| ABSIAbsci Corp | COM | 550,000 | $210.1 萬 | 0.7% | +550,000 | 新進 | 歷史 |
| NGNENeurogene Inc. | COM | 50,000 | $209.8 萬 | 0.7% | −20,000−28.6% | 減碼 | 歷史 |
| CAPRCapricor Therapeutics, Inc. | COM NEW | 125,000 | $190.1 萬 | 0.6% | +125,000 | 新進 | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 65,000 | $187.5 萬 | 0.6% | −70,000−51.9% | 減碼 | 歷史 |
| SMMTSummit Therapeutics Inc. | COM | 85,000 | $186.2 萬 | 0.6% | +85,000 | 新進 | 歷史 |
| SYRESpyre Therapeutics, Inc. | COM NEW | 60,000 | $176.5 萬 | 0.6% | −190,237−76.0% | 減碼 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 75,000 | $170.6 萬 | 0.6% | −512,708−87.2% | 減碼 | 歷史 |
| PRQRProQR Therapeutics N.V. | SHS EURO | 887,700 | $161.6 萬 | 0.6% | −12,300−1.4% | 減碼 | 歷史 |
| ATYRaTYR PHARMA INC | COM NEW | 800,000 | $140.8 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| LRMRLarimar Therapeutics, Inc. | COM | 200,000 | $131.0 萬 | 0.4% | +200,000 | 新進 | 歷史 |
| ENGNenGene Therapeutics Inc. | COM | 160,898 | $106.2 萬 | 0.4% | −259,433−61.7% | 減碼 | 歷史 |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | 325,000 | $105.3 萬 | 0.4% | +325,000 | 新進 | 歷史 |
選擇權（3 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
2024 年第 2 季之後清倉（18 檔）
2024 年第 2 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2024 年第 2 季股數 | 2024 年第 2 季市值 | 2024 年第 2 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| BHVNBiohaven Ltd. | COM | 490,000 | $1,701 萬 | 5.9% | 歷史 |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 22,500 | $546.8 萬 | 1.9% | 歷史 |
| ACADAcadia Pharmaceuticals Inc | COM | 225,000 | $365.6 萬 | 1.3% | 歷史 |
| CABACabaletta Bio, Inc. | COM | 370,899 | $277.4 萬 | 1.0% | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 33,200 | $179.9 萬 | 0.6% | 歷史 |
| ELEVElevation Acquisition Group Inc. | COM | 600,000 | $162.0 萬 | 0.6% | 歷史 |
| KRYSKrystal Biotech, Inc. | COM | 8,500 | $156.1 萬 | 0.5% | 歷史 |
| WVEWave Life Sciences, Inc. | SHS | 200,000 | $99.8 萬 | 0.3% | 歷史 |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 35,000 | $91.0 萬 | 0.3% | 歷史 |
| SGMTSagimet Biosciences Inc. | COM SER A | 225,000 | $77.0 萬 | 0.3% | 歷史 |
| ITCIIntra-Cellular Therapies, Inc. | COM | 10,000 | $68.5 萬 | 0.2% | 歷史 |
| MGNXMacrogenics Inc | COM | 150,000 | $63.8 萬 | 0.2% | 歷史 |
| PMVPPMV Pharmaceuticals, Inc. | COM | 375,000 | $60.8 萬 | 0.2% | 歷史 |
| PTCTPTC Therapeutics, Inc. | COM | 19,000 | $58.1 萬 | 0.2% | 歷史 |
| RVNCRevance Therapeutics, Inc. | COM | 225,000 | $57.8 萬 | 0.2% | 歷史 |
| NTLAIntellia Therapeutics, Inc. | COM | 25,000 | $56.0 萬 | 0.2% | 歷史 |
| ANTXAN2 Therapeutics, Inc. | COM | 219,331 | $47.2 萬 | 0.2% | 歷史 |
| CTMXCytomX Therapeutics, Inc. | COM | 300,000 | $36.6 萬 | 0.1% | 歷史 |